Parvovirus B19 Infection in Pregnancy: Awareness of the Increased Incidence of Severe Intrauterine Infection
Authors:
- Eleonora TorciaETEleonora Torcia
- Alessandra FamiliariAFAlessandra Familiari
- Elvira PassanantiEPElvira Passananti
- Maria Vittoria AlesiMAMaria Vittoria Alesi
- Giulia di MarcoGMGiulia di Marco
- Federica RomanziFRFederica Romanzi
- Marco De SantisMSMarco De Santis
- Tullio GhiTGTullio Ghi
- Elisa BevilacquaEBElisa Bevilacqua
Open Access
- 31 May 2025
- journal article
- opinion
- Published by MDPI AG in Diagnostics
- Vol. 15 (11) , 1397
Abstract
In 2024, Europe experienced a significant upsurge in cases of Parvovirus B19 (B19V), the etiological agent of erythema infectiosum, also known as fifth disease. The prevalence of B19V in pregnant women, a particularly vulnerable population, holds critical clinical significance. Typically, B19V follows a well-documented seasonal pattern, with annual epidemics peaking in the spring and larger outbreaks occurring approximately every four years. B19V exhibits a tropism for erythroid precursor cells, potentially resulting in fetal anemia and, in the most severe scenarios, intrauterine demise. Severe in utero infections necessitate intrauterine erythrocyte transfusion (IUT), a highly specialized and technically demanding procedure that is exclusively performed in tertiary-level prenatal care units. This study delineates how the notable increase in B19V infections is also reflected in our prenatal diagnosis unit at Fondazione Policlinico Agostino Gemelli (FPG) IRCCS, Rome, Italy. According to our case series, since 2018, B19V has been identified as the second most common cause of fetal anemia during the study period (29%, 6 patients), yet it accounted for the majority of IUT procedures performed in 2024 (16 out of 19 cases, 84.2%). Given the rising incidence of severe intrauterine infections in recent epidemic cycles, healthcare professionals should maintain a high index of suspicion regarding the clinical manifestations of maternal B19V infection and its potential obstetric complications. Further research is imperative to evaluate the cost-effectiveness of routine screening for B19V immunity in pregnant women and to investigate the long-term neurodevelopmental and clinical outcomes of neonates affected by intrauterine B19V infection.Keywords
This publication has 28 references indexed in Scilit:
- Impact of parvovirus B19 outbreak in a single centerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2024
- Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective studyArchives of Gynecology and Obstetrics, 2022
- Identification and management of congenital parvovirus B19 infectionPrenatal Diagnosis, 2020
- ISUOG Practice Guidelines: role of ultrasound in congenital infectionUltrasound in Obstetrics & Gynecology, 2020
- Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2018
- False-negative serology in patients with acute parvovirus B19 infectionJournal of Clinical Virology, 2011
- Parvovirus B19 infection in pregnancy: new insights and managementPrenatal Diagnosis, 2011
- Placental endothelial cells can be productively infected by Parvovirus B19Journal of Clinical Virology, 2009
- Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: Association with pathological findingsJournal of Medical Virology, 2008
- Fetal thrombocytopenia secondary to parvovirus infectionAmerican Journal of Obstetrics and Gynecology, 2007